These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 5925090)
1. [Interactions of the effects of various steroid structures. II. Anti-lipid and anti-atheromatous effects]. Savini EC Therapie; 1966; 21(4):959-66. PubMed ID: 5925090 [No Abstract] [Full Text] [Related]
2. [Arteriosclerosis with special reference to anticholesteremic agents]. Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239 [No Abstract] [Full Text] [Related]
3. [Configurative and cosmetic effects of steroid mixtures]. Stĕrba R; Valová B Cas Lek Cesk; 1967 Mar; 106(9):236-8. PubMed ID: 6047292 [No Abstract] [Full Text] [Related]
4. Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans seed extract. Sharma A; Mathur R; Dixit VP Indian J Physiol Pharmacol; 1995 Oct; 39(4):407-10. PubMed ID: 8582756 [TBL] [Abstract][Full Text] [Related]
5. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients]. Savenkov PM; Segal' RG Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695 [No Abstract] [Full Text] [Related]
6. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4915308 [No Abstract] [Full Text] [Related]
7. [Currently used therapeutic agents for arteriosclerosis--with special reference ro a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4916330 [No Abstract] [Full Text] [Related]
8. [Drugs for hyperlipemia]. Murakami M; Sekimoto H; Masuda S; Nagai T; Iwaki N Naika; 1968 Oct; 22(4):877-85. PubMed ID: 5710974 [No Abstract] [Full Text] [Related]
9. [Treatment of woman with sex steroids]. Staemmler HJ Ther Ggw; 1968 Sep; 107(9):1104 passim. PubMed ID: 5717231 [No Abstract] [Full Text] [Related]
10. The hypocholesterolemic and antiatherogenic effects of topically applied phosphatidylcholine in rabbits with heritable hypercholesterolemia. Hsia SL; He JL; Nie Y; Fong K; Milikowski C Artery; 1996; 22(1):1-23. PubMed ID: 8781707 [TBL] [Abstract][Full Text] [Related]
11. [Influence of 2-ethyl-3-(4-hydroxybenzoyl)-benzofuran (benzarone) on experimental atheromatosis (author's transl)]. Roth J; Betz E; Schlote W Arzneimittelforschung; 1980; 30(11):1897-902. PubMed ID: 7193000 [TBL] [Abstract][Full Text] [Related]
12. [Drugs for atherosclerosis]. Gaarenstroom JH Ned Tijdschr Geneeskd; 1966 Mar; 110(10):469-72. PubMed ID: 5324380 [No Abstract] [Full Text] [Related]
13. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618 [TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits. Sharma A; Mathur R; Dixit VP Indian J Exp Biol; 1995 Jun; 33(6):444-8. PubMed ID: 7590951 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of arteriosclerosis]. Murakami M Nihon Ishikai Zasshi; 1966 Feb; 55(3):471-84. PubMed ID: 5949726 [No Abstract] [Full Text] [Related]
16. [Hypocholesterolemic effect and lipid protection of the arterial wall by dimethyl-1,1-dioxa-2,8-hydroxyethyl-5-sila-1-aza-5-cyclooctane (T.E.A.S)]. Fourtillan JB; Dumas C; Pometan JP; Courtois P; Blondet Y Therapie; 1977; 32(4):517-24. PubMed ID: 605428 [No Abstract] [Full Text] [Related]
17. [Campaign against arteriosclerosis. Inhibition of cholesterol absorption in the future?]. MMW Fortschr Med; 2002 Sep; 144(35-36):50-1. PubMed ID: 12380357 [No Abstract] [Full Text] [Related]